Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method
Valérie Dubois(Établissement Français du Sang), Mauricette Michallet(Université Claude Bernard Lyon 1), Federico Garnier(Agence de la Biomédecine), C. Giannoli(Établissement Français du Sang), Marie Y. Detrait(Hôpital Civil de Charleroi), Nathalie Tedone(Hospices Civils de Lyon), Stéphane Morisset(Lyon 1 Université), Fiorenza Barraco(Hôpital Lyon Sud), Xavier Thomas(Hôpital Lyon Sud), Sylvie Rey, Philippe Moskovtchenko, Mohamad Sobh(Ottawa Hospital), Yves Bertrand(Hôpital Debrousse), Valérie Mialou(Institut d’Hématologie et d’Oncologie Pédiatrique), Franck E. Nicolini(Hôpital Lyon Sud), Sophie Ducastelle(Hôpital Lyon Sud), Hélène Labussière(Hôpital Lyon Sud), Évelyne Marry(Agence de la Biomédecine)
Cited by 10
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547